Please login (Members) to view content or
(Nonmembers) this article.
0

No votes yet

Oncology 101

To Screen or Not to Screen: Ongoing Debate in the Early Detection of Prostate Cancer

Joanna Marie Marroquin
CJON 2011, 15(1), 97-98 DOI: 10.1188/11.CJON.97-98

Debate about the use of prostate-specific antigen (PSA) tests to screen prostate cancer in men is ongoing. Prostate cancer is the most common cancer after skin cancer in men and the second most deadly after lung cancer. An elevated PSA level can lead to this cancer's diagnosis and treatment even before the onset of symptoms. However, other causes also can create a high PSA level, which may lead to men being unnecessarily treated for prostate cancer. This article will shed some light on the issue and discuss prostate cancer screening.

Members Only

Access to this article is restricted. Please login to view the full article.

Not a current ONS Member or journal subscriber?
Join/Renew Membership or